When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SYRS - Syros Pharma down 5% on updated data on lead candidate
Syros Pharmaceuticals Inc.
Thinly traded micro cap Syros Pharmaceuticals (SYRS-4.8%) slips on average volume on the heels of update results from its ongoing 40-subject Phase 2 clinical trial evaluating lead drug SY-1425, combined with chemo agent azacitidine, in newly diagnosed patients with relapsed/refractory acute myeloid leukemia (AML) who are unsuitable for standard chemo.
More news on: Syros Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,